A Northwestern University-led team of researchers has signed a cooperative agreement with the Defense Advanced Research Projects Agency (DARPA) to develop a wireless, fully implantable device that will control the body's circadian clock, halving the time it takes to recover from disrupted sleep/wake cycles.
Using a novel G-Putty material, scientists from AMBER, the SFI Centre for Advanced Materials and BioEngineering Research, and from Trinity’s School of Physics have designed an advanced graphene-based sensing technology.
Scientists have been developing a new sensor with the ability to detect Ebola in a single drop of blood and offer results within an hour.
During the initial days of the COVID-19 pandemic, doctors had found that patients who experienced a surge of pro-inflammatory immune proteins, called “cytokine storm,” were usually the sickest and faced the highest risk of death.
A tiny wireless implant developed by engineers from the University of California, Berkeley, can offer real-time measurements of tissue oxygen levels deep beneath the skin.
Skoltech researchers have developed a prototype of a fluorescence-based sensor for continuous detection of cortisol concentrations in real-time, which can help monitor various health conditions.
The idea of implantable sensors that continuously transmit information on vital values and concentrations of substances or drugs in the body has fascinated physicians and scientists for a long time.
The sustained overuse of antibiotics has caused the development of antibiotic-resistant pathogens, or the so-called “superbugs,” which can lead to acute, dangerous infections that should be diagnosed and treated at an early stage.
From swallowing pills to injecting insulin, patients frequently administer their own medication. But they don't always get it right. Improper adherence to doctors' orders is commonplace, accounting for thousands of deaths and billions of dollars in medical costs annually. MIT researchers have developed a system to reduce those numbers for some types of medications.
Melbourne-based research and advanced manufacturing company Sleeptite, today launched REMi – a world first, non-invasive resident monitoring and alert system that has the potential to revolutionise the aged care industry.